April 4, 2018 Dr. Chakravarti Selected to Serve on NCI Advisory Board of Scientific Counselors

April 04 2018

In his new role, Dr. Chakravarti will be chairing the review of the NCI Radiation Oncology Program and of the NCI Neuro-Oncology Program in future years.Dr. Chakravarti’s experience includes research regarding novel biomarkers and uncovering key molecular and genetic mechanisms of treatment resistance in cancer. His team was among the first to report that the dysregulation of PI3K/AKT signaling is associated with radiation resistance in glioblastomas. 

News

Back

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.